Phase 3 Readout~month

Phase 3 Topline: A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Ei

Indication
Schizophrenia

Other upcoming events for VNDA

Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Tradipitant on Naus
Phase 3 ReadoutPhase 3 Topline: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficac
Phase 3 ReadoutPhase 3 Topline: Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participa
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety o

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Ei — VNDA Phase 3 Readout | BioSniper